
Champions Oncology Inc
NASDAQ:CSBR


to continue CSBR research
to continue CSBR research
You've reached your weekly stock limit.
Sign UpChampions Oncology Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.79
11.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Champions Oncology Inc hold over its rivals?
What risks and challenges
does Champions Oncology Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Champions Oncology Inc.
Provide an overview of the primary business activities
of Champions Oncology Inc.
What unique competitive advantages
does Champions Oncology Inc hold over its rivals?
What risks and challenges
does Champions Oncology Inc face in the near future?
Has there been any significant insider trading activity
in Champions Oncology Inc recently?
Summarize the latest earnings call
of Champions Oncology Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Champions Oncology Inc.
Provide P/S
for Champions Oncology Inc.
Provide P/E
for Champions Oncology Inc.
Provide P/OCF
for Champions Oncology Inc.
Provide P/FCFE
for Champions Oncology Inc.
Provide P/B
for Champions Oncology Inc.
Provide EV/S
for Champions Oncology Inc.
Provide EV/GP
for Champions Oncology Inc.
Provide EV/EBITDA
for Champions Oncology Inc.
Provide EV/EBIT
for Champions Oncology Inc.
Provide EV/OCF
for Champions Oncology Inc.
Provide EV/FCFF
for Champions Oncology Inc.
Provide EV/IC
for Champions Oncology Inc.
Show me price targets
for Champions Oncology Inc made by professional analysts.
What are the Revenue projections
for Champions Oncology Inc?
How accurate were the past Revenue estimates
for Champions Oncology Inc?
What are the Net Income projections
for Champions Oncology Inc?
How accurate were the past Net Income estimates
for Champions Oncology Inc?
What are the EPS projections
for Champions Oncology Inc?
How accurate were the past EPS estimates
for Champions Oncology Inc?
What are the EBIT projections
for Champions Oncology Inc?
How accurate were the past EBIT estimates
for Champions Oncology Inc?
Compare the revenue forecasts
for Champions Oncology Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Champions Oncology Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Champions Oncology Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Champions Oncology Inc compared to its peers.
Compare the P/E ratios
of Champions Oncology Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Champions Oncology Inc with its peers.
Analyze the financial leverage
of Champions Oncology Inc compared to its main competitors.
Show all profitability ratios
for Champions Oncology Inc.
Provide ROE
for Champions Oncology Inc.
Provide ROA
for Champions Oncology Inc.
Provide ROIC
for Champions Oncology Inc.
Provide ROCE
for Champions Oncology Inc.
Provide Gross Margin
for Champions Oncology Inc.
Provide Operating Margin
for Champions Oncology Inc.
Provide Net Margin
for Champions Oncology Inc.
Provide FCF Margin
for Champions Oncology Inc.
Show all solvency ratios
for Champions Oncology Inc.
Provide D/E Ratio
for Champions Oncology Inc.
Provide D/A Ratio
for Champions Oncology Inc.
Provide Interest Coverage Ratio
for Champions Oncology Inc.
Provide Altman Z-Score Ratio
for Champions Oncology Inc.
Provide Quick Ratio
for Champions Oncology Inc.
Provide Current Ratio
for Champions Oncology Inc.
Provide Cash Ratio
for Champions Oncology Inc.
What is the historical Revenue growth
over the last 5 years for Champions Oncology Inc?
What is the historical Net Income growth
over the last 5 years for Champions Oncology Inc?
What is the current Free Cash Flow
of Champions Oncology Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Champions Oncology Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Champions Oncology Inc
NASDAQ:CSBR
|
113.6m USD | 13.8 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 280.1 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
150.2B USD | 16.2 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
140.5B USD | 20.6 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
70.8T KRW | 32.1 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
39.1B CHF | 22.6 |
|
JP |
D
|
DNA Chip Research Inc
TSE:2397
|
6.8T JPY | 69 428.2 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
32.8B USD | 19.1 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
26.9B USD | 11.3 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
185.1B CNY | 15.8 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
24B USD | 21 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Champions Oncology Inc
NASDAQ:CSBR
|
Average EV/EBITDA:
6 443.7
13.8
|
N/A | N/A | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 280.1
|
7%
|
182.9 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
16.2
|
6%
|
2.7 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
20.6
|
7%
|
2.9 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
32.1
|
17%
|
1.9 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
22.6
|
18%
|
1.3 |
|
JP |
D
|
DNA Chip Research Inc
TSE:2397
|
69 428.2
|
N/A | N/A |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
19.1
|
10%
|
1.9 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
11.3
|
9%
|
1.3 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
15.8
|
24%
|
0.7 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
21
|
4%
|
5.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.